NSERC Prizes
Synergy Award for Innovation
Michael Organ
Toronto Research Chemicals, an LGC company
University Partnerships
When the global pandemic struck in 2020, Toronto Research Chemicals, an LGC company (LGC-TRC), was one of very few companies worldwide manufacturing a particular trifunctional non-nucleoside linker, a key molecule necessary for some brands of COVID-19 test kits. LGC-TRC had prepared this material in small quantities using batch-reactor technology for more than a decade, but the company found itself needing to scale up production immediately. Unfortunately, the method used for small-scale batch production presented hazards that made it too risky to attempt the procedure at multi-kilo scale. Alternate reaction conditions had been tried over the preceding years to no avail.
LGC-TRC contacted Professor Michael Organ, a pioneer of flow chemistry, and asked if new technology could be developed to prepare the material in a safer and more sustainable fashion. Organ’s team responded with a groundbreaking solution, delivering a novel reactor design that enables the carrying out of the hazardous transformation in flow – for the first time ever – and the preparation of billions of COVID-19 test kits. New flow-reactor technology was rapidly developed and the University of Ottawa trainees who invented it installed the ultimate prototype at LGC-TRC and trained employees on its operation and maintenance.
The speed with which this partnership achieved success played a key part in helping the world begin to move again after the first complete lockdown and laid the foundation for an enduring and impactful partnership for the future.
For additional information or to request photos of NSERC Prize winners, please contact Media Relations.